CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific today launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that ...
Here I review the applications of Ion Torrent NGS technology in the field of microbiome research and some recent publications about it. With Ion Torrent 16S rRNA next generation sequencing, there are ...
The Icahn Institute for Genomics and Multiscale Biology at Mount Sinai has purchased a suite of 16 next-generation sequencing (NGS) systems and ancillary technology from Thermo Fisher Scientific’s Ion ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Today Thermo Fisher Scientific announced that it has released a next-generation sequencing (NGS) RNA panel and workflow that enables targeted sequencing of fusion ...
HERCULES, Calif., Aug 12, 2013 (BUSINESS WIRE) -- "We have been providing next-generation sequencing and bioinformatics services to research centers, and universities all around the world since 2009.
Thermo Fisher Scientific Inc. TMO recently launched the Ion Torrent Genexus Dx Integrated Sequencer. This CE-IVD marked automated, next-generation sequencing (NGS) platform delivers results within a ...
The leading scientific social networking website and producer of educational virtual events and webinars.
The Ion S5 and Ion S5 XL benchtop systems use Ion Torrent technology and can be scaled for research areas, including infectious agents and microbial identification. The systems combine the ability to ...
Automation of library preparation is highly crucial for decreasing the possibilities of error, increasing reproducibility, and minimizing the amount of hands-on time, enabling scientists to produce ...
SAN DIEGO, Feb. 6, 2012 /PRNewswire/ - AltheaDx announced today that it has achieved authorized customer service provider (CSP) status in Ion Torrent's new service provider program. The CSP ...
Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions A patient’s tumor profile has the potential ...